SCHEMBL19215380

SCHEMBL19215380

NC(=O)c1cccc(NC(=O)CCCCC(=O)Nc2cccc(C(N)=O)c2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 1.00
KMT2A Q03164 2/20 1.00
PARP1 P09874 5/20 0.81
PARP10 Q53GL7 5/20 0.81
HDAC1 Q13547 5/20 0.59
HDAC6 Q9UBN7 5/20 0.59
HDAC3 O15379 4/20 0.59
HDAC2 Q92769 4/20 0.59
HDAC10 Q969S8 4/20 0.59
HDAC11 Q96DB2 4/20 0.59
HDAC8 Q9BY41 4/20 0.59
HDAC4 P56524 3/20 0.59
HDAC7 Q8WUI4 3/20 0.59
HDAC9 Q9UKV0 3/20 0.59
HDAC5 Q9UQL6 3/20 0.59
SMN1; SMN2 Q16637 2/20 0.56
HTT P42858 2/20 0.56
PARP14 Q460N5 3/20 0.55
PARP15 Q460N3 2/20 0.55
NPC1 O15118 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14567079 0.94 KMT2A (0.88) MEN1KMT2APARP1PARP10HDAC1
SCHEMBL18671651 0.93 KMT2A (0.87) MEN1KMT2APARP1PARP10SMN1; SMN2
SCHEMBL882827 0.91 MEN1 (0.83) MEN1KMT2APARP1PARP10HDAC1
SCHEMBL9453278 0.91 MEN1 (0.83) MEN1KMT2APARP1PARP10HDAC1
SCHEMBL13370421 0.90 MEN1 (0.81) MEN1KMT2APARP1PARP10HDAC1
SCHEMBL26100331 0.89 MEN1 (0.79) MEN1KMT2APARP1PARP10HDAC1
SCHEMBL26102702 0.88 MEN1 (0.77) MEN1KMT2APARP1PARP10HDAC1
SCHEMBL30493621 0.88 MEN1 (0.77) MEN1KMT2APARP1PARP10HDAC1
SCHEMBL3362788 0.87 MEN1 (0.77) MEN1KMT2APARP1PARP10SMN1; SMN2
SCHEMBL3646991 0.87 MEN1 (0.76) MEN1KMT2APARP1PARP10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020154434-A1 COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING COGNITIVE DYSFUNCTION PHARMATROPHIX, INC. (US) 2020-07-30 WO disclosed
EP-2526942-B1 Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics UNIV NORTH CAROLINA CHAPEL HILL (US) 2017-08-09 EP disclosed